Associate professor Frank Dekker was awarded an NWO ENW-M1 grant for a research project on Hypoxia-induced drug activation to enhance ferroptosis as a new treatment strategy for Acute Myeloid Leukaemia.
The current therapy for Acute Myeloid Leukemia (AML) suffers from development of therapy resistance. Cancer cells responsible for development of therapy resistance reside in the bone marrow in a low oxygen environment. A mechanism that enables killing of therapy resistant cancers cells is called ferroptosis. The project aims to enhance the ferroptosis process by development of a novel therapeutic strategy. This strategy involves development of molecules that are activated by low oxygen concentrations and trigger degradation of proteins that suppress ferroptosis and thus enhance this process. Thus, this strategy will enable eradication of cancer cells that are resistant to chemotherapy, which will postpone or abolish relapse into cancer progression.
Every two weeks, UG Makers puts the spotlight on a researcher who has created something tangible, ranging from homemade measuring equipment for academic research to small or larger products that can change our daily lives. That is how UG...
As a part of the Jantina Tammes School, the 'Language and AI' theme is an interdisciplinary initiative that aims to encourage collaboration among academics, PhD candidates, students, and industry representatives who share a keen interest in the...
Prof. Moniek Tromp has been appointed Captain of Science of the Chemistry Top Sector by the Minister of Economic Affairs and Climate Policy. As from 1 July 2023, she succeeded Prof. Bert Weckhuysen from Utrecht University.
The UG website uses functional and anonymous analytics cookies. Please answer the question of whether you want to accept
or reject other cookies (such as tracking cookies).
If no choice is made, only basic cookies will be stored. More information